These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1860681)
21. Free and conjugated catecholamines in patients with cirrhosis. Gaudin C; Braillon A; Selz F; Cuche JL; Lebrec D J Lab Clin Med; 1990 May; 115(5):589-92. PubMed ID: 2341761 [TBL] [Abstract][Full Text] [Related]
22. Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol. Snady H; Lieber CS Am J Gastroenterol; 1988 Mar; 83(3):249-55. PubMed ID: 3344727 [TBL] [Abstract][Full Text] [Related]
23. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis. Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061 [TBL] [Abstract][Full Text] [Related]
24. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437 [TBL] [Abstract][Full Text] [Related]
25. Splanchnic and renal contribution to disposal of infused epinephrine in humans. Saccà L; Hendler R; Picardi A; Sherwin RS Am J Physiol; 1986 Sep; 251(3 Pt 1):E285-9. PubMed ID: 3752240 [TBL] [Abstract][Full Text] [Related]
26. Increased spillover of norepinephrine to the portal vein during CO-pneumoperitoneum in pigs. Myre K; Rostrup M; Eriksen M; Buanes T; Raeder J; Stokland O Acta Anaesthesiol Scand; 2004 Apr; 48(4):443-50. PubMed ID: 15025606 [TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of the contribution of hepatic, renal and portal circulation to the clearance of exogenous catecholamines. Sumikawa K; Hirano H Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):337-46. PubMed ID: 3175332 [TBL] [Abstract][Full Text] [Related]
28. Effects of propranolol on renal blood flow and renal function in patients with cirrhosis. Bataille C; Bercoff E; Pariente EA; Valla D; Lebrec D Gastroenterology; 1984 Jan; 86(1):129-33. PubMed ID: 6357936 [TBL] [Abstract][Full Text] [Related]
30. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493 [TBL] [Abstract][Full Text] [Related]
31. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552 [TBL] [Abstract][Full Text] [Related]
32. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension. Vlavianos P; Mac Mathuna P; Williams R; Westaby D Clin Sci (Lond); 1999 May; 96(5):475-81. PubMed ID: 10209079 [TBL] [Abstract][Full Text] [Related]
33. Influence of beta blockade on branched chain amino acid concentrations in cirrhosis. Eriksson LS; Söderman C Hepatogastroenterology; 1992 Oct; 39(5):451-4. PubMed ID: 1459531 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis. Braillon A; Calès P; Lebrec D Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165 [TBL] [Abstract][Full Text] [Related]
35. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Henriksen JH; Ring-Larsen H; Kanstrup IL; Christensen NJ Gut; 1984 Oct; 25(10):1034-43. PubMed ID: 6479678 [TBL] [Abstract][Full Text] [Related]
36. Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade. Bendtsen F; Gerbes AL; Henriksen JH Scand J Clin Lab Invest; 1993 Oct; 53(6):547-54. PubMed ID: 8265999 [TBL] [Abstract][Full Text] [Related]
37. Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol. Valla D; Gaudin C; Geoffroy P; Braillon A; Lee SS; Lebrec D J Hepatol; 1987 Feb; 4(1):86-92. PubMed ID: 3494761 [TBL] [Abstract][Full Text] [Related]
38. Effects of circulating catecholamines on hepatic blood volume in anesthetized cats. Greenway CV; Dettman R; Burczynski F; Sitar DS Am J Physiol; 1986 Jun; 250(6 Pt 2):H992-7. PubMed ID: 3717370 [TBL] [Abstract][Full Text] [Related]
39. Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis. Braillon A; Gaudin C; Poo JL; Moreau R; Debaene B; Lebrec D Hepatology; 1992 Jan; 15(1):58-62. PubMed ID: 1727800 [TBL] [Abstract][Full Text] [Related]
40. Release and clearance rates of epinephrine in man: importance of arterial measurements. Best JD; Halter JB J Clin Endocrinol Metab; 1982 Aug; 55(2):263-8. PubMed ID: 7085853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]